학술논문
A prospective evaluation of circulating tumor cells and cell-free DNA in EGFR-mutant non-small cell lung cancer patients treated with erlotinib on a phase II trial
Document Type
Article
Author
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 15 December 2016, 22(24):6010-6020)
Subject
Language
English
ISSN
15573265
10780432
10780432